Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,933
Out of 4,963 analysts
6
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $1.58 | +26.58% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $40.80 | +132.84% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $95.12 | +31.41% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $4.53 | +120.75% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $16.14 | -7.06% | 1 | Nov 11, 2022 |
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $1.58
Upside: +26.58%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $40.80
Upside: +132.84%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $95.12
Upside: +31.41%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $4.53
Upside: +120.75%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $16.14
Upside: -7.06%